Speaker
Scott DeWire, PhD
US HEAD, BUSINESS DEVELOPMENT & LICENSING, BOEHRINGER INGELHEIM
Ridgefield, Connecticut, United States
Scott is currently Head of Business Development and Licensing, USA at Boehringer Ingelheim, based
out of both Ridgefield, CT and Cambridge, MA. He received his BS in Cellular Biology from the
University of Connecticut and began his research career with Pfizer in Groton, CT. He later earned a
PhD in Molecular Biology from the University of North Carolina and did his postdoc at the lab of
Nobel Laureate Robert Lefkowitz at Duke University, studying G protein coupled receptor
signaling. In late 2007, Scott co-founded a start-up company called Trevena Inc ($TRVN on Nasdaq),
helping discover and develop Olinvyk®. After his startup adventure, Scott left Trevena to join BI,
initially working in the research group. Scott later moved to lead Cancer Immunology BD&L and
assumed his current role as head of the US BD&L team in early 2020
out of both Ridgefield, CT and Cambridge, MA. He received his BS in Cellular Biology from the
University of Connecticut and began his research career with Pfizer in Groton, CT. He later earned a
PhD in Molecular Biology from the University of North Carolina and did his postdoc at the lab of
Nobel Laureate Robert Lefkowitz at Duke University, studying G protein coupled receptor
signaling. In late 2007, Scott co-founded a start-up company called Trevena Inc ($TRVN on Nasdaq),
helping discover and develop Olinvyk®. After his startup adventure, Scott left Trevena to join BI,
initially working in the research group. Scott later moved to lead Cancer Immunology BD&L and
assumed his current role as head of the US BD&L team in early 2020
Speaking In
2:15 PM - 2:30 PM
Wednesday, June 7
